U.S., Oct. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07871513) titled 'A Study to Assess the Safety and Efficacy of Co-Reconstituted TrenibotulinumtoxinE and OnabotulinumtoxinA in Adult Participants With Moderate to Severe Upper Facial Lines' on Oct. 07.
Brief Summary: The objective of this Phase 2 study is to assess the safety and efficacy of single treatment of trenibotulinumtoxinE and onabotulibumtoxinA combination in adult participants with moderate to severe upper facial lines. The study has two parts; Part 1 evaluates treatment for glabellar lines.
Study Start Date: Oct. 07
Study Type: INTERVENTIONAL
Condition:
Upper Facial Lines
Glabellar Lines
Intervention:
DRUG: TrenibotulinumtoxinE and ...